Publicaciones (24) Publicaciones de JUANA GIL HERRERA

2024

  1. Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation

    Blood, Vol. 143, Núm. 10, pp. 872-881

2023

  1. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

2022

  1. More difficult still: Treating severe rapidly progressive glomerulonephritis in the context of COVID-19 pneumonia

    Nefrologia, Vol. 42, Núm. 1, pp. 94-98

2021

  1. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations

    Journal of Allergy and Clinical Immunology, Vol. 148, Núm. 5, pp. 1332-1341.e5

  2. Lymphocyte subsets early predict mortality in a large series of hospitalized COVID-19 patients in Spain

    Clinical and Experimental Immunology, Vol. 203, Núm. 3, pp. 424-432

  3. Next Generation Sequencing for Detecting Somatic FAS Mutations in Patients With Autoimmune Lymphoproliferative Syndrome

    Frontiers in Immunology, Vol. 12

  4. The age again in the eye of the COVID-19 storm: evidence-based decision making

    Immunity and Ageing, Vol. 18, Núm. 1

2020

  1. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  2. Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 9, pp. 438-443

  3. Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 8, Núm. 10, pp. 3342-3347

  4. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

2019

  1. Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis

    Clinica Chimica Acta, Vol. 488, pp. 135-142

  2. Primary and secondary immunodeficiency diseases in oncohaematology: Warning signs, diagnosis, and management

    Frontiers in Immunology, Vol. 10, Núm. MAR

  3. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults

    Blood, Vol. 133, Núm. 23, pp. 2465-2477

2018

  1. Acquired angioedema with anti–C1-inhibitor autoantibodies during assisted reproduction techniques

    Journal of Investigational Allergology and Clinical Immunology

2017

  1. Primary T-cell immunodeficiency with functional revertant somatic mosaicism in CD247

    Journal of Allergy and Clinical Immunology, Vol. 139, Núm. 1, pp. 347-349.e8

2016

  1. A case of IL-7R deficiency caused by a novel synonymous mutation and implications for mutation screening in SCID diagnosis

    Frontiers in Immunology, Vol. 7, Núm. OCT

  2. Multicenter study for the evaluation of the antibody response against salmonella typhi Vi vaccination (EMPATHY) for the diagnosis of Anti-polysaccharide antibody production deficiency in patients with primary immunodeficiency

    Clinical Immunology, Vol. 169, pp. 80-84

2013

  1. Sequential combined therapy with Omalizumab and Rituximab: A new approach to severe atopic dermatitis

    Journal of Investigational Allergology and Clinical Immunology, Vol. 23, Núm. 3, pp. 190-196

2009

  1. Association of monoclonal expansion of Epstein-Barr virus-negative CD158a+ NK cells secreting large amounts of gamma interferon with hemophagocytic lymphohistiocytosis

    Clinical and Vaccine Immunology, Vol. 16, Núm. 1, pp. 142-145